Expanded Access to ABBV-787
Sponsor: AbbVie
ClinicalTrials ID:NCT06439966
This expanded access program provides ABBV-787 via IV infusion to eligible participants who cannot join an ABBV-787 clinical trial. A medical doctor must assess the potential benefits and risks based on the patient's medical history and program criteria. Availability is subject to territory eligibility and local regulatory approval.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-787 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.
Eligibility Criteria
Inclusion Criteria
- The participant must not be eligible for an ABBV-787 clinical trial.
Get This Program In Your Inbox
You can sign up and apply your patients for this program.